MicroVAX's Unattributed - II Round

MicroVAX raised a round of funding on April 14, 2015.

MicroVAX is a clinical stage biotech company dedicated to the development of potent vaccines, for treatment and preventive purposes, having application to the areas of cancer and infectious diseases f…

Articles about MicroVAX's Unattributed - II Round: